1. |
Yang L, Liu J, Su Q, et al. Novel and de novo mutation of PCDH19 in girls clustering epilepsy. Brain Behav, 2019, 9(12): e01455.
|
2. |
Vlaskamp DRM, Bassett AS, Sullivan JE, et al. Schizophrenia is a later-onset feature of PCDH19 girls clustering epilepsy. Epilepsia, 2019, 60(3): 429-440.
|
3. |
Depienne C, LeGuern E. PCDH19-related infantile epileptic encephalopathy: an unusual X-linked inheritance disorder. Hum Mutat, 2012, 33(4): 627-634.
|
4. |
Sadleir LG, Kolc KL, King C, et al. Levetiracetam efficacy in PCDH19 girls clustering epilepsy. Eur J Paediatr Neurol, 2020, 24: 142-147.
|
5. |
Samanta D. PCDH19-related epilepsy syndrome: a comprehensive clinical review. Pediatr Neurol, 2020, 105: 3-9.
|
6. |
Sullivan J, Gunning B, Zafar M, et al. Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Res, 2023, 191: 107112.
|
7. |
Trivisano M, Pietrafusa N, Terracciano A, et al. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: a multicenter study. Epilepsia, 2018, 59(12): 2260-2271.
|
8. |
Kowkabi S, Yavarian M, Kaboodkhani R, et al. PCDH19-clustering epilepsy, pathophysiology and clinical significance. Epilepsy Behav, 2024, 154: 109730.
|
9. |
Moncayo JA, Ayala IN, Argudo JM, et al. Understanding protein protocadherin-19 (PCDH19) syndrome: a literature review of the pathophysiology. Cureus, 2022, 14(6): e25808. Published 2022 Jun 10.
|
10. |
Gecz J, Thomas PQ. Disentangling the paradox of the PCDH19 clustering epilepsy, a disorder of cellular mosaics. Curr Opin Genet Dev, 2020, 65: 169-175.
|
11. |
Chen Y, Liu A, Zhang X, et al. Seizure course of PCDH19 clustering epilepsy in female children: A multicentre cohort study in China. Dev Med Child Neurol, 2024, 66(6): 804-815.
|
12. |
Smith L, Singhal N, El Achkar CM, et al. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum. Epilepsia, 2018, 59(3): 679-689.
|
13. |
Zhu J, Liu Z, Geng F, Peng J, Li Z, Yang Q. Prenatal diagnosis of developmental and epileptic encephalopathy 9 with a 10.05-Mb microdeletion at Xq21.31q22.1 inherited from mother: a case report and literature review. Mol Genet Genomic Med, 2024, 12(1): e2338.
|
14. |
Kolc KL, Sadleir LG, Scheffer IE, et al. A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity. Mol Psychiatry, 2019, 24(2): 241-251.
|
15. |
Zhou W, Ouyang Y, Ji Y, Xi Q, Zhao L. Genetic variants and phenotype analysis in a five-generation Chinese pedigree with PCDH19 female-limited epilepsy. Front Neurol, 2023, 14: 1107904. Published 2023 Mar 9.
|
16. |
Trivisano M, Pietrafusa N, Ciommo Vd, et al. PCDH19-related epilepsy and Dravet syndrome: face-off between two early-onset epilepsies with fever sensitivity. Epilepsy Res, 2016, 125: 32-36.
|
17. |
Trivisano M, Specchio N. The role of PCDH19 in refractory status epilepticus. Epilepsy Behav, 2019, 101(Pt B): 106539.
|
18. |
Feng W, Wang Z, Wang X, et al. Phenotypic and genotypic characteristics of children with PCDH19 clustering epilepsy in China. Seizure, 2024, 121: 95-104.
|
19. |
Lotte J, Bast T, Borusiak P, et al. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. Seizure, 2016, 35: 106-110.
|
20. |
Nagarajan L, Ghosh S, Dyke J, et al. Epilepsy surgery in PCDH 19 related developmental and epileptic encephalopathy: a case report. Epilepsy Behav Rep, 2022, 19: 100560.
|